Semnur Pharmaceuticals, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Semnur Pharmaceuticals, Inc. (SMNR) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-05-12
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 S-1 · filed 2026-05-12 |
| 2024-12-31 | $0.00 S-1 · filed 2026-05-12 |